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The increasing burden of chronic kidney disease places
enormous strains on resources of all countries, but especially
of those with emerging economies. Few developing
countries are able to afford dialysis programs and those that
do ration this scarce resource. In South Africa, rationing has
been practiced since the introduction of dialysis. Our renal
unit carefully screened patients with end-stage kidney
disease (ESKD) based on certain medical and socioeconomic
criteria. The outcome of these decisions taken by the
Assessment Committee is reviewed in this study. Details of
the 2442 patients with ESKD assessed between 1988 and
2003 for the renal replacement program were captured.
Using univariate and multivariate analysis, the odds of being
accepted for treatment based on several variables were
determined. The majority (52.7%) of patients with ESKD were
not offered renal replacement therapy in the period of study.
The number of kidney transplants progressively decreased,
as did the number of patients accepted. The patients mostly
likely to be accepted for renal replacement therapy were
aged 20–40 years, white, employed, married, non-diabetic,
and lived in proximity to a dialysis center. Almost 60% of
patients were denied renal replacement treatment because
of social factors related to poverty. In a developing country,
where rationing of treatment is unavoidable, it is difficult to
ensure equity of treatment and certain groups are
advantaged over others. In our experience, socioeconomic
factors influenced decision to accept patients more
profoundly than medical ones.
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Protagonists of renal medicine in developing countries face
challenges completely different from those of their peers
practicing in the West. The constraints on capital and human
resources combined with a rapidly escalating chronic kidney
disease burden places immense pressures on clinicians in
developing countries who are forced to ration renal replace-
ment treatment.1,2 All the reasons for the rising incidence of
chronic kidney disease are uncertain, but the increase in the
global type II diabetes mellitus epidemic which is affecting
developing countries more severely, with a commensurate
increase in diabetic nephropathy is almost certainly one of
them.3–5 The other important risk factor for chronic kidney
failure is possibly the ageing of the population. Even in
developing countries, the population is rapidly aging as
infectious diseases are brought under control1 and the
incidence of chronic kidney disease is higher in the elderly
compared with the rest of the population.6
Worldwide, the prevalence of patients requiring main-
tenance dialysis treatment is increasing at an alarming 7% per
annum.7 The cost of treating these patients is set to escalate
to an extent that will stretch the resources of even the
wealthiest nations and it would not be surprising to see
the return of some form of rationing in these countries. In
the United States of America, there is a projected increase
in spending to US$ 28 billion by 2010. More alarming is the
prediction that by 2010 the number of patients with end-
stage kidney failure will exceed two million globally and the
aggregate cost of treatment for the millennium ending 2010
will exceed US$1 trillion.7 Developing countries are predicted
to shoulder a disproportionate share of this disease burden.8
Compounding this is the AIDS pandemic that bites deeply
into the health budget of countries in sub-Saharan Africa at
the expense of other health priorities. In the West, rationing
of dialysis was practiced 40 years ago when this new treat-
ment modality was introduced. Rationing was the function of
the so-called ‘Life or Death Committees’,9 but the introduc-
tion of free or subsidized treatment in developed countries
with almost universal entitlement allowed these committees
to be dispensed with.10 However, in developed countries
rationing in renal replacement treatment continues to be
practiced with the allocation of organs for transplantation. In
this regard, it is clear that disparities exist that compromise
those who are black, women, aged, and the poor.11–14
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In developing countries where there is limited access to
dialysis, some form of rationing has always been practiced.15
Only a minority of patients with end-stage kidney disease
(ESKD) in these countries enjoys access to renal replacement
treatment; for the rest the diagnosis of chronic renal failure
is a death sentence. Patients from middle-income countries
such as South Africa have access, albeit limited, to renal
replacement treatment. In 1997, the National Department of
Health in South Africa drew up guidelines to formalize the
selection process and assist nephrologists in the difficult task
of patient selection. At most State institutions selection
committees reminiscent of the ‘Life or Death Committees’
are responsible for making the final decision. At our
institution, rationing has been the norm since the initiation
of our renal replacement program in 1976 and draconian
reductions in resources for chronic dialysis in the middle
1990s enforced further rationing. This is a report of the out-
come of the decisions taken by the Assessment Committee
operating at our institution. It highlights the tragic conse-
quences of well intentioned but enforced actions and begs the
rationality of these decisions.
RESULTS
The total number of patients assessed increased dramatically
in 1990 and since then has maintained a high cyclical trend,
whereas the number of patients accepted has been decreasing
(Figure 1). Over the same period, the number of kidney
transplants performed annually has decreased dramatically
(Figure 2). Of the 2442 patients assessed over the 15-year
period of the study, 1155 (47%) were accepted for renal
replacement treatment and 1287 (53%) were treated conser-
vatively. Of the patients refused treatment, 743 (59%) were
denied primarily owing to social factors (Figure 3). These
social factors were associated with poverty, and included
living circumstances that were unsuitable for continuous
ambulatory dialysis, unemployment, lack of insight into
illness, lack of education/illiteracy, criminal record, poor
compliance, substance abuse, traveling difficulties. In many
cases, a combination of social circumstances and medical
factors mitigated against a patient’s acceptance for treatment.
Details of the patients are shown in Table 1. The patients
accepted for treatment were significantly younger than the
patients treated conservatively. Only 17 (1.3%) patients 60
years and older were accepted, although this age group
comprised 221 (17%) of the patients treated conservatively
(Po0.001). More white patients were accepted compared to
non-white (black and colored) patients (Po0.001). Chronic
glomerulonephritis accounted for 41% of all-cause ESKD.
Diabetes mellitus and hypertension accounted for 15.8% and
15.1% of all primary causes of ESKD, respectively. The
etiology of ESKD in the two groups was comparable except
for the disproportionate number of diabetics ((305 (25%)
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Figure 1 | Outcome of assessments of patients with advanced
chronic kidney disease.
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Figure 2 | The number of kidney transplants performed from
1988 to 2003.
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Figure 3 | Primary reasons for the non-acceptance of patients for
renal replacement treatment. The majority of patients with ESKD
fail to qualify for treatment for poverty-related problems such
illiteracy, lack of funds to travel to the treatment center, and poor
record of compliance. The main medical problem was the presence of
cardiovascular disease. Although the presence of HIV/AIDS is a
problem in sub-Saharan Africa, only 16 patients were HIV positive and
refused treatment in the last 5 years. This could be because many
patients with HIV infection died of other complications before they
develop HIV-associated nephropathy. Alternatively, these patients
were not referred because our policy of not accepting these patients
for renal replacement treatment was well known by our referring
structures.
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compared to 70 (6%), Po0.01)) in the group treated
conservatively (Figure 4). The odds of being accepted for
treatment were calculated for a number of variables and are
shown in Tables 2 and 3. Patients aged between 20 and
40 years were the most likely to be accepted and those over
60 years the least. Of greater concern was that white patients
were almost four times more likely to be accepted for
treatment than non-white patients. There was no gender
difference in the chances of receiving treatment. Patients
who contributed to society by being employed and who
were therefore making a contribution to the economy were
also favored. Both marital status and parenthood played
important roles in the selection of the patients.
Owing to the exploratory nature of the classification and
regression tree analysis, a randomly selected hold-out sample
(30% of the data) was used to verify the results. Three major
variables namely employment, age, and race was identified
as influencing the acceptance rates. The acceptance was low
(16%) in unemployed patients regardless of age and race.
Employed patients aged o50 years enjoyed the highest
acceptance rate (79%). Patients, who were non-white,
employed, and older than 50 years had low acceptance rates
(11%) compared to white employed patients over 50 years
who had acceptance rates of 67%.
DISCUSSION
The need to ration expensive medical services is a reality in
most developing countries. Our data show that over the past
decade the number of patients accepted has been steadily
decreasing both in absolute as well as relative terms. The
reasons for this are twofold. The primary reason is the cons-
traints placed on health budgets by local health authorities,
which are mainly responsible for health funding in the public
sector, which serves the majority of South African popula-
tion. In 1997, the funding of our dialysis unit was capped to
allow treatment of 80 patients with ESKD and has remained
unchanged since. The second is the declining transplant rate,
which has been experienced nationally as well internationally
and the reasons for which remain speculative.17 In 2002,
the non-acceptance rate peaked at 69.6%. For the decade
1993–2003, the acceptance rate for renal replacement treat-
ment at our institution has been falling on average 1.5% per
annum, whereas the growth of the Western Cape population
annually averaged 2.9% between 1996 and 2001 (Statistics
South Africa, 2001, Pretoria, Report 03-02-13). The decli-
ning treatment rate in our unit contrasts sharply with the
steadily rising incidence of renal replacement in developed
countries.18 The rates have varied between countries but have
been as high as 11% in Japan19 and averaging between 3 and
4.3% in Europe. In the latter, the elderly benefited the most
with the greatest increase in dialysis rate being in patients
aged over 75 years and contrasts sharply with our own
experience where very few patients over 60 years receive
treatment.18
The average annual cost of renal replacement therapy per
patient far exceeds the gross domestic income per capita of
most of developing countries.15 In South Africa, the gross
domestic product per capita was US$3480 in 2004. In the
same year, the annual cost of hemodialysis for a single patient
Table 1 | Comparison of demographic details of 2442 ESKD
patients assessed for renal replacement treatment.
Rejected
n=1287 (52.7%)
Accepted
n=1155 (47.2%) P-value
Mean age (CI) 47.0 (46.3–47.8) 36.6 (37.0–38.3) o0.01
Sex 0.7
Male (%) 669 (52.0) 591 (51.2)
Female (%) 618 (48.0) 564 (48.8)
Race o0.01a
Black (%) 133 (10.3) 141 (12.2)
Colored (%) 953 (74.0) 691 (59.8)
White (%) 201 (15.6) 323 (28.0)
CI, 95% confidence interval; ESKD, end-stage kidney disease.
aWhite versus non-white (colored and black) patients.
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Figure 4 | Etiology of chronic renal failure in two groups of patients based on the outcome of assessment for renal replacement
treatment. The main difference between the two groups was that fewer patients with diabetes were accepted for treatment.
GN, glomerulonephritis.
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in our unit was US$9130, whereas continuous ambulatory
peritoneal dialysis (CAPD) cost US$8319 (unpublished data).
The cost of dialysis is therefore prohibitive and the majority
of patients, even if reasonably affluent, would find dialysis a
major financial hardship. Of all the patients in South Africa,
82% rely on the State for health funding and 18% on
privately funded medical schemes that contribute signifi-
cantly to the cost of dialysis treatment.20 The other problems
of the provision of renal services to a large population are
common to most developing countries (Table 4).21 In a
country where infectious diseases such as tuberculosis and
AIDS continue to take a massive human toll, access to basic
health care, improvements in nutrition, and access to basic
facilities such as running water, sanitation, and electricity are
a priority, renal replacement therapy unfortunately does not
yet enjoy much support from health authorities.
It is well known that minority groupings are less likely to
access certain forms of medical interventions. There are
gender-based disparities in accessing cancer-screening tests,
cardiovascular procedures, and medications for human
immunodeficiency virus (HIV).12 The race-based differences
in accessing treatment or interventions are even better
known22–24 and include access to renal replacement therapy.25
In our unit, patients were selected using criteria that took
into consideration both psychosocial and medical factors, but
with the former influencing decision making more than the
latter. The criteria were later formalized by the National
Department of Health.26 The single most important criterion
determining selection was suitability for kidney transplanta-
Table 2 | Univariate analysis of ESKD patients selected for treatment
Variable Level N Accepted (%)a P-value Odds ratio 95% CI
Renal disease Diabetic 416 20
Non-diabetic 1998 57 o0.01 5.14 4.06 6.52
Age o20 years 119 62
20–40 years 1135 67
41–60 years 885 39
460 years 235 7 o0.01 —
Race Colored 1633 44
Whites 540 75
Blacks 241 43 o0.01
Gender Male 1206 50
Female 1208 51 0.54 1.05 0.90 1.23
Marital status Never married 515 34
Ever Married 1239 38 0.07 1.22 0.98 1.51
Dependents Yes 900 55
No 1370 48 o0.01 1.32 1.12 1.57
Region Metropole 1608 51
Distance from dialysis center (km) 51–100 297 51
101–200 254 39
4200 122 45 o0.01 —
Employment Unemployed 733 7
Employed 924 55 o0.01 17.13 13.07 22.44
CI, 95% confidence interval; ESKD, end-stage kidney disease.
aNote that percentages will not necessarily add up to 100% because the percentage accepted patients is for different groups.
Table 3 | Results of the best subsets logistics regression
analysis
Variable Odds ratio 95% CI P-value
Age 0.91a 0.89 0.93 o0.01
White race 3.87 2.3 6.50 o0.01
Married 5.99 3.12 11.51 o0.01
Employed 5.42 3.12 9.39 o0.01
CI, 95% confidence interval; ESKD, end-stage kidney disease.
aThis is the odds ratio for 1 year intervals. For 10-year-intervals it is 0.38
(95% CI: 0.30–0.47).
Table 4 | Factors limiting provision of renal replacement
services in poor countries
1 Lack of financial resources
2 Lack of human resources
3 Rural location of population
4 Other health priorities
5 Lack of governmental will
6 HIV/AIDS in sub-Saharan Africa
7 Lack of basic amenities
8 Inaccessibility/lack of cheap transport
9 Late diagnosis of chronic kidney disease
10 Poor nutrition
HIV, human immunodeficiency virus.
Adapted from Chugh and Jha.21
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tion. If patients were unable to receive organs they were
summarily denied dialysis treatment. The medical reasons
that excluded patients from treatment included advanced
disease of other vital organ systems, advanced malignancies,
or severe psychiatric disease. The second important con-
sideration was the ability of patients to access treatment
facilities. The unit serves a large agricultural community in
towns and villages situated vast distances from the main
dialysis treatment center. The population serviced was largely
indigent with lack of adequate access to basic facilities such as
potable water and electricity. CAPD was often considered and
used in certain situations, although the household setup for
CAPD was unsatisfactory in most cases. Due consideration
was given to how patients started on CAPD would be
managed should the technique fail. Finally, the treatment was
preferably offered to those patients who the Assessment
Committee felt would derive the greatest overall benefit.
Unemployed patients were deemed to place an additional
burden on a social welfare system already struggling to meet
the needs of its citizens; selection thus favored the employed
and those who were responsible for the care and support of
dependants. Younger patients were also, arguably, favored
because it was felt that they were likely to derive greater
benefit than the elderly who also were more likely to have co-
morbid diseases. As dialysis was performed mainly in urban
areas, patients in rural settings (who comprised about one
half of the population) were disadvantaged. One way of
overcoming this problem is to decentralize dialysis to nodal
units that can service several surrounding villages and towns.
In the United Kingdom, almost 40% of patients receive their
treatment in satellite units. It has been shown that these units
can service a large part of the dialysis population and can be
effectively operated by nursing staff alone without an onsite
nephrologist.27
The declining number of transplants being performed is of
great concern, but is part of a countrywide and international
trend, and its relation to the increasing difficulty to enter the
renal replacement program is coincidental. Because of the
high incidence of end-stage kidney failure in our population,
all available ‘slots’ for dialysis are readily filled with deserving
patients and to ensure turnover kidney transplantation is
crucial. Without an active transplant program, the dialysis
program would be doomed to stagnation. Innovative ways of
enhancing kidney transplantation need to be investigated.17
An important factor, which is difficult to quantify (but
often taken into consideration by the Committee) and
limiting the provision of renal replacement treatment in
developing countries is the lack of skilled personnel to care
for patients (Figure 5). South Africa has a well-developed
health structure quite capable of training medical and
paramedical staff, but lack of adequate career pathing, poor
salaries, and lack of a structured health plan has resulted in
severe disillusionment among South African health profes-
sionals in the public sector, who leave for private sector
employment or, more commonly, for countries such as
Canada, United States of America, and the United Kingdom
as well as the Middle-Eastern countries where they are in
great demand.28,29 All areas of health including the care of
renal patients suffer as a result. Anecdotally, the situation
arises not infrequently where capital resources are available
but the lack of trained staff prevent expansion of the renal
replacement program. Reversing this ‘brain-drain’ remains a
major challenge for the heath authorities.
With the basic criteria to guide the Assessment Commit-
tee, it is interesting to note the outcome of these delibera-
tions. Although every effort was made to ensure equity in the
allocation of renal services, it is clear that white patients were
much more likely to be treated than other race groups. This
implies that white patients were more likely to satisfy the
suggested guidelines than non-white patients. White patients
were more likely to live closer to dialysis centers, and be
employed than non-whites as a result of the privileged status
of these patients under the previous political dispensation,
which continues to exert an influence on life in South Africa.
The other important determinant of acceptance was the age
of the patient. Very few patients over the age of 60 years were
treated, the assumption being that the risk of complications
and mortality increase with age (as would costs), but more
importantly perhaps, that younger patients would be able to
benefit more and for longer than older patients following
kidney transplantation. This approach to the elderly is
very debatable and probably unfairly discriminates against a
very vulnerable group in the society.30,31 Mallick and de
Caestecker32 eloquently argue that the younger patient
starting dialysis at 30 years and surviving for 30 years will
consume more resources than an elderly patient allowed
three or four additional years to enjoy with his family. Less
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Figure 5 | Human resources. There was a decline in all levels of renal
personnel. What is not reflected here is the high personnel turnover.
In the study period, for example, seven nephrologists left the service
for the private sector or work abroad, and they were replaced by
younger less experienced specialists. Similarly, among nurses the
turnover was even greater with the depletion of skilled health-care
staff. There was a progressive decline in the number of technologists
mainly as a result of attrition. For most of the 1990s, there was a
moratorium on the filling of posts and when this was lifted posts
could not be filled except by trainees because of a national shortage
of skilled dialysis staff, both technical and nursing.
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than 16% of patients in this cohort were diabetic and only
18.6% of diabetic patients who were assessed were accepted
for renal replacement treatment. The reluctance to accept
diabetic patients was based on observations that diabetic
patients had a worse outcome both on dialysis and
transplantation. These patients were more likely to have
and develop complications, and as such were more costly to
maintain on treatment. Although the experience in developed
countries has shown improved survival, this remains to be
shown for those in developing countries.33 Married patients
and those employed were also favored. This reflects the
principle that favors patients with dependants and those
making an economic contribution to society. Although we
showed no gender differences in the treatment of patients
with kidney failure, in many developing countries female
patients make up a much smaller proportion of ESKD
patients treated. This is almost certainly the result of social
and cultural factors that favor the treatment of men.15,34
The acceptance rate for renal replacement therapy varies
in different regions of developing countries with a clear
relationship to the wealth of individual nations.2,35,36 This is
illustrated by the remarkable growth of dialysis facilities with
the burgeoning economies of the previous Soviet bloc
countries.37 On the Indian sub-continent, only 3–5% of all
patients with ESKD receive any form of renal replacement. Of
those who start hemodialysis, some 60% are lost to follow-up
within 3 months as the economic realities of the treatment
come into play.38 Whereas screening of ESKD patients is
practiced throughout the public sector hospitals in South
Africa, it is less clear how other emerging countries decide on
whom to accept for treatment.2,39 In many countries, patients
are often only offered acute treatment for a limited period of
time, during which time they need to produce a living kidney
donor or are required to fund ongoing dialysis from own
sources.40–42
It is clear from this investigation that the process of
selection of patients for renal replacement treatment, even
with the best intentions, is severely flawed and leads to
inequity in service delivery. The most adversely affected are
the poor (represented in this study by non-white patients)
and the elderly. A similar problem was faced in USA before
the Medicare was extended to all patients with ESKD and
social factors were taken into consideration. As in this study,
selection for the dialysis program favored the young, white,
male, and the employed patients.43 Current reports show that
where doctors’ discretion is required in waitlisting white,
male, young high income patients are more likely to receive
cadaveric transplants.14,44–47 The problem can be improved
by empowering and uplifting the poor that will have the
effect of reducing certain forms of renal disease and allowing
greater access to treatment options. With its vast and growing
population, South Africa faces a major challenge. Indicators
are that the economy should grow at the rate of 3–5% per
annum, but it has been predicted that by 2010, the AIDS
epidemic could cost South Africa as much as 17% in gross
domestic product growth. Investment in other chronic
diseases is therefore unlikely to be a priority, but every effort
should be made on behalf of society to overcome the
prejudice against renal patients. The prevalence of chronic
kidney disease is rapidly rising worldwide at an estimated 8%
annually48 and it is likely that developing countries such as
South Africa are even more vulnerable. Early intervention of
chronic kidney disease and the correct management of
diabetes mellitus and hypertension may stem the tide.13
Health authorities need to realize that chronic kidney disease
is as much a social, economic, and ethical problem, as it
is a medical one.49 Unless there is a concerted effort
by governmental health agencies together with medical
authorities to address the problem the consequences are
likely to be dire.
MATERIALS AND METHODS
Since the inception of the renal replacement program some 30 years
ago, records have been kept at our institution of the decisions made
by the Assessment Committee responsible for assessing the
suitability of patients with ESKD for renal replacement treatment.
Our center offers chronic dialysis (hemodialysis and CAPD) as well
as kidney transplantation. The center is situated in the metropolis of
Cape Town with three satellite hemodialysis units all approximately
100 km from the main center serving some of the rural population.
The main treatment center is situated at a teaching hospital that
serves approximately one-half of the four million (census 2004)
population of the Western Cape region of South Africa. The dialysis
program was initiated in 1976, but for the purposes of this study we
limited ourselves to reviewing the data between 1988 and 2003 when
information was reliably computerized. The Assessment Committee
consisted of the attending nephrologists, responsible physician,
social worker, renal nursing staff, and renal technologists; at
least one representative of each category of health-care worker
was present at each meeting, which was held weekly. Hospital
administrators had a standing invitation, whereas attempts to
involve lay persons were unsuccessful. The committee was appointed
by the head of the health institution according to the guidelines
from the National Department of Health and reported to the
hospital authorities. Psychological evaluations of patients were
requested from time to time. Decisions to accept patients for renal
replacement treatment were generally based on medical criteria
(transplantability being the main one) and social criteria (employ-
ment, housing status, marital status, dependants, and distance from
a treatment center). Difficult to document but also considered
at assessment was the availability of resources (both human and
capital) for dialysis at the time of evaluation. All patients were
included in the analysis; referring physicians were encouraged to
present all ESKD patients, even patients such as the elderly and those
with advanced AIDS who were unlikely to be offered renal
replacement treatment, for assessment, and to let the committee
make the final decision.
Over the 15-year period of the study, 2442 patients were assessed,
of whom 48.3% were female. The mean age of the patients was 42.6
years (95% confidence interval:42.1–43.2). The main reason(s) for
refusing treatment was noted. The effect of variables on the odds of
being accepted for the program was statistically analyzed. Three
separate analyses were performed. Firstly, the effect of each of the
variables on its own was investigated by cross-tabulations and
calculating the w2 test to determine significant dependencies
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(univariate analysis). Where applicable, odds ratios were also
calculated. The variables that were chosen included demographic
factors, marital status, dependants, employment status, distance
from the treatment center, and primary renal disease. Secondly, to
determine the combined effect of the variables on acceptance for
treatment, a best subsets logistic regression was performed. The
purpose of this method was to determine the optimal subset of
variables that had the best predictive power for acceptance. Thirdly,
classification and regression tree analysis was used to determine
which variables are important in determining acceptance. The
advantage of this method is that it can handle combinations of
categorical and continuous variables, and it has the ability to derive
rules from the data, which gives more insight into the data.
Classification and regression tree splits a continuous variable into
two classes and defines two subspaces that maximize overall class
separation. These subspaces each then serves as basis for further
partitioning independently of the others. At each step, the variable
used for each split is selected from all the predictor variables so as to
provide an optimal partition given the previous actions.16 All values
are means and 95% confidence intervals. Continuous data were
analyzed using Student’s t-test and categorical data w2 test. These
tests were performed on an IBM compatible computer, using
Statistica for Windows version 7.0. (Statsoft Inc., 2004, Tulsa, OK,
USA). Significance was set at the 5% level. This study was approved
by the Committee for Human Research of the University of
Stellenbosch.
ACKNOWLEDGMENTS
We thank Professor Razeen Davids and Dr Theo Hattingh for critically
reviewing this manuscript.
REFERENCES
1. El Nahas AM, Bello AK. Chronic kidney disease: the global challenge.
Lancet 2005; 365: 331–340.
2. Barsoum RS. Chronic kidney disease in the developing world. N Engl
J Med 2006; 354: 997–999.
3. Wild S, Roglic G, Green A et al. Global prevalence of diabetes: estimates
for the year 2000 and projections for 2030. Diabetes Care 2004; 27:
1047–1053.
4. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025:
prevalence, numerical estimates, and projections. Diabetes Care 1998; 21:
1414–1431.
5. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes
and its complications: estimates and projections to the year 2010. Diabet
Med 1997; 14(Suppl 5): S1–85.
6. USRDS. The United States Renal Data System. Am J Kidney Dis 2003;
42(Suppl 5): 1–230.
7. Lysaght MJ. Maintenance dialysis population dynamics: current trends
and long-term implications. J Am Soc Nephrol 2002; 13(Suppl 1): S37–S40.
8. Atkins RC. The changing patterns of chronic kidney disease: the need to
develop strategies for prevention relevant to different regions and
countries. Kidney Int 2005; 68(Suppl 98): S83–S85.
9. Alexander S. They decide who lives, who dies. Life 1962; 9: 103–125.
10. Rettig RA. The social contract and the treatment of permanent kidney
failure. JAMA 1996; 275: 1123–1126.
11. Furth SL, Garg PP, Neu AM et al. Racial differences in access to the kidney
transplant waiting list for children and adolescents with end-stage renal
disease. Pediatrics 2000; 106: 756–761.
12. Garg PP, Furth SL, Fivush BA, Powe NR. Impact of gender on access to the
renal transplant waiting list for pediatric and adult patients. J Am Soc
Nephrol 2000; 11: 958–964.
13. Bello AK, Nwankwo E, El Nahas AM. Prevention of chronic kidney disease:
a global challenge. Kidney Int 2005; 68(Suppl. 98): S11–S17.
14. Kjellstrand CM. Age, sex, and race inequality in renal transplantation.
Arch Intern Med 1988; 148: 1305–1309.
15. Moosa MR, Walele AA, Daar AS. Renal transplantation in developing
countries. In: Morris PJ (eds). Kidney Transplantation: Principles and
Practice. WB Saunders: Philadelphia, 2001 pp. 659–692.
16. Gaudart J, Poudiougou B, Ranque S, Doumbo O. Oblique decision trees
for spatial pattern detection: optimal algorithm and application to
malaria risk. BMC Med Res Methodol 2005; 5: 22.
17. Buckley TA. The shortage of solid organs for transplantation in
Hong Kong: part of a worldwide problem. Hong Kong Med J 2000; 6:
399–408.
18. Stengel B, Billon S, Van Dijk PC et al. Trends in the incidence of renal
replacement therapy for end-stage renal disease in Europe, 1990–1999.
Nephrol Dial Transplant 2003; 18: 1824–1833.
19. Usami T, Koyama K, Takeuchi O et al. Regional variations in the incidence
of end-stage renal failure in Japan. JAMA 2000; 284: 2622–2624.
20. Goudge J. The Public-Private Mix. South African Health Review. SA Health
Systems Trust: Durban, 1999: 69–82.
21. Chugh KS, Jha V. Differences in the care of ESRD patients worldwide:
required resources and future outlook. Kidney Int 1995; 48(Suppl 50):
S7–13.
22. Whittle J, Conigliaro J, Good CB, Lofgren RP. Racial differences in the use
of invasive cardiovascular procedures in the Department of Veterans
Affairs medical system. N Engl J Med 1993; 329: 621–627.
23. Goldberg KC, Hartz AJ, Jacobsen SJ et al. Racial and community factors
influencing coronary artery bypass graft surgery rates for all 1986
Medicare patients. JAMA 1992; 267: 1473–1477.
24. Schulman KA, Berlin JA, Harless W et al. The effect of race and sex on
physicians’ recommendations for cardiac catheterization. N Engl J Med
1999; 340: 618–626.
25. Barker-Cummings C, McClellan W, Soucie JM, Krisher J. Ethnic differences
in the use of peritoneal dialysis as initial treatment for end-stage renal
disease. JAMA 1995; 274: 1858–1862.
26. Naicker S. End-stage renal disease in sub-Saharan and South Africa.
Kidney Int 2003; 63(Suppl 83): S119–S122.
27. Feest TG, Rajamahesh J, Byrne C et al. Trends in adult renal replacement
therapy in the UK: 1982–2002. Quart J Med 2005; 98: 21–28.
28. Editorial. Migration of health workers: an unmanaged crisis. Lancet 2005;
365: 1825.
29. Eastwood JB, Conroy RE, Naicker S et al. Loss of health professionals from
sub-Saharan Africa: the pivotal role of the UK. Lancet 2005; 365:
1893–1900.
30. Gotloib L. Moneytheism and the crime of being old. Nephron 2000; 85:
191–193.
31. Berlyne GM. Medical concerns and the national budget allocations.
Nephron 1995; 71: 125–126.
32. Mallick NP, de Caestecker MP. The changing population on renal
replacement therapy: its clinical and economic impact in Europe. Nephrol
Dial Transplant 1996; 11(Suppl 2): S2–S5.
33. Breyer J. Diabetic nephropathy. In: Greenberg A, Cheung AK, Coffman
TM, et al. (eds). Primer on Kidney Diseases. Academic Press: San Diego, CA,
1998, pp 215–220.
34. Barsoum RS. Overview: end-stage renal disease in the developing world.
Artif Organs 2002; 26: 737–746.
35. Mircescu G, Capsa D, Covic M et al. Nephrology and renal replacement
therapy in Romania – transition still continues (Cinderella story revisited).
Nephrol Dial Transplant 2004; 19: 2971–2980.
36. Zatz R, Romao JE, Noronha IL. Nephrology in Latin America, with special
emphasis on Brazil. Kidney Int 2003; 63(Suppl 83): S131–S134.
37. Rutkowski B. Highlights of the epidemiology of renal replacement
therapy in Central and Eastern Europe. Nephrol Dial Transplant 2006; 21:
4–10.
38. Kher V. End-stage renal disease in developing countries. Kidney Int 2002;
62: 350–362.
39. Sitprija V. Nephrology in South East Asia: fact and concept. Kidney Int
Suppl 2003; 63(Suppl 83): S128–S130.
40. Fernandez-Cean J, Gonzalez-Martinez F, Schwedt E, Mazzuchi N. Renal
replacement in Latin America. Kidney Int 2000; 57(Suppl 74): S55–S59.
41. Barsoum RS. End-stage renal disease in North Africa. Kidney Int 2003;
63(Suppl 83): S111–S114.
42. Sakhuja V, Sud K. End-stage renal disease in India and Pakistan: burden of
disease and management issues. Kidney Int 2003; 63(Suppl 83):
S115–S118.
43. Evans RW, Blagg CR, Bryan Jr FA. Implications for health care policy.
A social and demographic profile of hemodialysis patients in the
United States. JAMA 1981; 245: 487–491.
44. Kasiske BL, Neylan III JF, Riggio RR et al. The effect of race on access and
outcome in transplantation. N Engl J Med 1991; 324: 302–307.
45. Held PJ, Pauly MV, Bovbjerg RR et al. Access to kidney transplantation.
Has the United States eliminated income and racial differences? Arch
Intern Med 1988; 148: 2594–2600.
Kidney International (2006) 70, 1107–1114 1113
MR Moosa and M Kidd: Dangers of rationing care o r i g i n a l a r t i c l e
46. Sanfilippo FP, Vaughn WK, Peters TG et al. Factors affecting the waiting
time of cadaveric kidney transplant candidates in the United States.
JAMA 1992; 267: 247–252.
47. Gaylin DS, Held PJ, Port FK et al. The impact of comorbid and
sociodemographic factors on access to renal transplantation. JAMA 1993;
269: 603–608.
48. Schieppati A, Remuzzi G. Chronic renal diseases as a public health
problem: epidemiology, social, and economic implications. Kidney Int
Suppl 2005; 68(Suppl 98): S7–S10.
49. Kaseje DC, Juma P, Oindo M. Public health in Africa: what is new – the
context, the gains, the losses, the renewed public health, and the way
forward. Kidney Int 2005; 68(Suppl 98): S49–S59.
1114 Kidney International (2006) 70, 1107–1114
o r i g i n a l a r t i c l e MR Moosa and M Kidd: Dangers of rationing care
